Technologie-Atlas
Wissenschaftlerin mit Pipette in einem hellen biomedizinischen Labor

Projekt

A20 als Immunmodulator in Lungenkrebs

KRAS driven lung cancer, Anti-Inflammatory A20, Mouse Models Of Disease, Immune Checkpoint Blockade, Adotive Immune Cell Therapy, Anti-Tumor Immunity, Naturwissenschaften, Humanmedizin, Gesundheitswissenschaften, Biologie, Medizinisch-theoretische Wissenschaften, Pharmazie, Molekularbiologie, Krebsforschung

KRAS driven lung cancer, Anti-Inflammatory A20, Mouse Models Of Disease, Immune Checkpoint Blockade, Adotive Immune Cell Therapy, Anti-Tumor Immunity, Naturwissenschaften, Humanmedizin, Gesundheitswissenschaften, Biologie, Medizinisch-theoretische Wissenschaften, Pharmazie, Molekularbiologie, Krebsforschung

Weiter entdecken

Ähnliche Beiträge

6 Empfehlungen
Projekt A20: Metamorphose eines Tumorsuppressors EGFR-driven lung adenocarcinoma, Tumor immune microenvironment, A20 (TNFAIP3) signaling, Immunotherapy responsiveness, STAT1/IFN… Beitrag ansehen Projekt Komplexe Organoid Kulturen als präklinische Modelle für CRC Colorectal Cancer, Tumor Microenvironment, Cancer Associated Fibroblasts, Immune Cells, Organoid, Targeted Therapy, Naturwissensc… Beitrag ansehen Projekt Identification of novel therapeutic approaches to target the immune checkpoint protein B7H3 Immunotherapies have revolutionized the treatment of multiple cancer types in the last decade. Nonetheless, non-small cell lung c… Beitrag ansehen Projekt Exploration of targeting GPR56 and its cancer cell ligand as a novel immune checkpoint inhibition strategy Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy over the last decade. In essence, ICIs block the interacti… Beitrag ansehen Projekt Investigate the mode of action ofInvestigate the mode of action of beta-carboline derivative Harmine on increasing MHC-I expression and potentiating the Immune Checkpoint Blockade cancer immunotherapy One of the major mechanisms by which solid tumors escape anti-tumor immunity is the downregulation of major histocompatibility co… Beitrag ansehen Projekt REPRESSIT: A novel class of clinical immune checkpoint inhibitors In the tumor microenvironment, continuous or “tonic” stimulation of T cells induces checkpoint signaling through inhibitory immun… Beitrag ansehen

Passend zu diesem Beitrag

Hochschulen

1 Verknüpfungen

Passend zu diesem Beitrag

Förderungen

1 Verknüpfungen